Abera Bioscience AB (NGM:ABERA)
Sweden · Delayed Price · Currency is SEK 7.50
-0.30 (-3.85%)
At close: Aug 8, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 111.30 million as of August 14, 2025. Its market cap has increased by 71.39% in one year.
Market Cap
111.30M
Enterprise Value
105.80M
Revenue
15.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.50
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has decreased from 115.59M to 111.30M, a decrease of -3.70%. That is a compound annual growth rate of -0.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 113.61M | 64.08% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | 115.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 883.30B |
| Atlas Copco AB | 686.46B |
| AB Volvo | 590.20B |
| EQT AB | 395.36B |
| ASSA ABLOY AB | 365.89B |
| Skandinaviska Enskilda Banken AB | 350.65B |
| Swedbank AB | 303.77B |
| Sandvik AB | 297.67B |